PharmaRoth Labs (PharmaRoth Labs) EPS (Basic) : $-0.00 (TTM As of Mar. 2011)

View and export this data going back to 2008. Start your Free Trial

What is PharmaRoth Labs EPS (Basic)?

PharmaRoth Labs's basic earnings per share (Basic EPS) for the three months ended in Mar. 2011 was $0.00. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2011 was $-0.00.

PharmaRoth Labs's EPS (Diluted) for the three months ended in Mar. 2011 was $0.00. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2011 was $-0.00.

PharmaRoth Labs's EPS without NRI for the three months ended in Mar. 2011 was $0.00. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2011 was -0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

PharmaRoth Labs EPS (Basic) Historical Data

The historical data trend for PharmaRoth Labs's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaRoth Labs EPS (Basic) Chart

PharmaRoth Labs Annual Data

Trend

Jun08

Jun09

Jun10

EPS (Basic)

PharmaRoth Labs Quarterly Data
	Mar07	Sep07	Dec07	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11
EPS (Basic)	Get a 7-Day Free Trial											-	-	-	-	-

PharmaRoth Labs EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

PharmaRoth Labs's Basic EPS for the fiscal year that ended in Jun. 2010 is calculated as

Basic EPS (A: Jun. 2010 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-0.27	-	0)	/	46.738
	=	-0.01

PharmaRoth Labs's Basic EPS for the quarter that ended in Mar. 2011 is calculated as

Basic EPS (Q: Mar. 2011 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-0.101	-	0)	/	137.768
	=	-0.00

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2011 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.00

PharmaRoth Labs (GREY:ROTH) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

PharmaRoth Labs EPS (Basic) Related Terms

Thank you for viewing the detailed overview of PharmaRoth Labs's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

PharmaRoth Labs (PharmaRoth Labs) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PharmaRoth Labs Inc (GREY:ROTH) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

N/A

Address

8250 West Charleston Boulevard, Suite 110, Las Vegas, NV, USA, 89117

Website

http://www.pharmaroth.com

PharmaRoth Labs Inc is engaged in the manufacture and sale of a treatment for Type II diabetes called Sucanon. The company also does marketing and selling of nutraceutical drugs.

PharmaRoth Labs (PharmaRoth Labs) Headlines

From GuruFocus

Hotchkis and Wiley Value Opportunities Fund Buys Rothschild SCA, Oracle Corp, Medtronic PLC, Sells Amerco Inc, Anthem Inc, F5 Inc

By GuruFocusNews insider • 03-29-2022